Quantitative Health Sciences

Medicine & Life Sciences

1. Neoplasms 100%
2. Population 98%
3. Breast Neoplasms 93%
4. Confidence Intervals 90%
5. Survival 85%
6. Systematic Reviews 81%
7. Meta-Analysis 80%
8. Alzheimer Disease 77%
9. Genes 73%
10. Single Nucleotide Polymorphism 65%
11. Therapeutics 64%
12. Odds Ratio 63%
13. Incidence 56%
14. Mortality 55%
15. Cohort Studies 49%
16. Cognitive Dysfunction 49%
17. Biomarkers 48%
18. Genome-Wide Association Study 47%
19. Mutation 46%
20. Colorectal Neoplasms 41%
21. Electronic Health Records 41%
22. Ovarian Neoplasms 40%
23. Genome 40%
24. Rheumatoid Arthritis 40%
25. Clinical Trials 39%
26. Prostatic Neoplasms 38%
27. Dementia 37%
28. Epidemiology 37%
29. Case-Control Studies 36%
30. Randomized Controlled Trials 35%
31. Guidelines 35%
32. Heart Failure 34%
33. Health 34%
34. Pancreatic Neoplasms 33%
35. Physicians 32%
36. Alleles 32%
37. Lung Neoplasms 31%
38. Quality of Life 31%
39. Drug Therapy 30%
40. Delivery of Health Care 30%
41. Databases 30%
42. Amyloid 30%
43. Tendons 28%
44. Recurrence 28%
45. Costs and Cost Analysis 28%
46. Non-Hodgkin's Lymphoma 27%
47. Genotype 27%
48. Phenotype 26%
49. Irritable Bowel Syndrome 25%
50. Placebos 25%
51. Logistic Models 25%
52. Colonic Neoplasms 25%
53. Atrial Fibrillation 24%
54. B-Cell Chronic Lymphocytic Leukemia 24%
55. Body Mass Index 24%
56. Datasets 24%
57. Proteins 23%
58. Myocardial Infarction 23%
59. Kidney 22%
60. Elderly 22%
61. Radiotherapy 22%
62. Pharmacogenetics 22%
63. Breast Density 21%
64. Child 21%
65. Hospital Emergency Service 21%
66. Stroke 21%
67. Hospitalization 21%
68. Transplants 21%
69. Adenocarcinoma 20%
70. Smoking 20%
71. Progression-Free Survival 20%
72. Genetic Variation 20%
73. Serum 20%
74. Exercise 20%
75. Pharmaceutical Preparations 19%
76. Medical Records 19%
77. Obesity 19%
78. Cardiovascular Diseases 19%
79. Practice Guidelines 19%
80. Shared Decision Making 18%
81. African Americans 18%
82. Brain 18%
83. Breast 18%
84. Biopsy 18%
85. Depression 18%
86. Ovarian Epithelial Carcinoma 18%
87. Genomics 18%
88. Research Personnel 18%
89. Comorbidity 17%
90. DNA 17%
91. Registries 17%
92. Safety 17%
93. Non-Small Cell Lung Carcinoma 17%
94. Prospective Studies 17%
95. Atrophy 16%
96. Education 16%
97. Statistics 16%
98. Wrist 16%
99. Liver Transplantation 16%